(Wilmington, N.C.) ProtonMedia and PPD, Inc. (Nasdaq: PPDI) today announced they have entered into an agreement to jointly develop a new virtual clinical trial training solution that will improve the cost effectiveness, speed and quality of clinical trial training for life sciences organizations. (more…)

(Research Triangle Park, N.C.) Carolyn Finkle, Vice President of Regulatory Consulting for North America at Catalent Pharma Solutions will have a leading role in this year’s Pharmaceutical Education and Research Institute (PERI) by teaching a spring and fall course on drug development. The spring course is entitled, “Basic Drug Development: From Molecule to Market” and will be held at the PERI training facility located in Arlington, VA on March 14 to March 15, 2011 from 8 a.m. to 5 p.m. on each day. (more…)

(Research Triangle Park, N.C.) Alan Hendricker, Ph.D., Principal Scientist of Structural Chemistry, and Thomas Feinberg, Ph.D., Director of Structural Chemistry, at Catalent Pharma Solutions will have prominent roles at this year’s PQRI workshop entitled “Thresholds and Best Practices for Parenteral and Ophthalmic Drug Products (PODP).” The workshop will be held at the Hyatt Regency in Bethesda, MD on February 22-23, 2011. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) today announced that David L. Grange plans to retire as chief executive officer of PPD and a member of its board of directors. Grange joined PPD’s board in 2003 and served with distinction as an independent director until mid-2009 when he became chief executive officer. Grange’s retirement will be effective May 18, 2011, the date of the company’s annual shareholder meeting. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions’ team of experts, Dr. David Igo and Dr. Pingyun Chen, will be presenting at the upcoming Informex USA conference, February 7-10, 2011, in Charlotte, NC. The team of Optiform™ Technologies experts will present, “Efficient Solid-State Screening Using FT-Raman Spectroscopy” at the technology showcase on Monday, February 7, 2011 at 9:00 AM. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) today announced that BioDuro, A PPD® Company, was named the 22nd fastest-growing technology company in Asia Pacific in the 2010 Deloitte Technology Fast 500 Asia Pacific list of companies. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) today announced it has established a joint venture with Taijitu Biologics Limited (TBL) in the area of the discovery of novel biotherapeutics. The joint venture, named BioDuro Biologics, expands PPD’s capability to deliver unique, highly differentiated drug discovery services for biopharmaceutical companies across the globe. (more…)

(Research Triangle Park, N.C.) Catalent Pharma Solutions announces the installation of electronic verification applications at its Clinical Supply Services facilities in Philadelphia, PA and Schorndorf, Germany. The addition of these automated process check stations is part of an ongoing investment to reduce customer costs and proactively increase service quality standards to better meet clinical trial needs globally. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) announced it has appointed Elena Logan as senior vice president of global central labs. In this role, Ms. Logan will provide strategic direction for the company’s state-of-the-art global central laboratory operations, which are strategically located across three continents. (more…)

(Morrisville, N.C.)  Synteract, Inc., www.synteract.com, a full-service contract research organization (CRO) founded in 1995 and dedicated to meeting the clinical research needs of biotechnology, medical device, and pharmaceutical companies, has tripled its office space in its Research Triangle Park location and will add up to 30 positions before the end of 2011. The company, which is based in San Diego, planned the North Carolina expansion to better meet the needs of East Coast clients by providing local support and expertise in the same time zone. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) today announced it has appointed Andreas Tschirky, Ph.D., as leader of BioDuro. In this role, Dr. Tschirky will have responsibility for providing scientific and operational leadership and managing the growth of the Beijing-based drug discovery services company PPD acquired last year. (more…)

(Research Triangle Park, N.C.) Quintiles, today announced the official opening of its new Global Information Technology (IT) Service Operations Center in Bangalore, India. The Service Operations Center provides intelligent monitoring, control and triage of system events across Quintiles’ technology cloud – its shared, managed and secure computing environment. The Service Operations Center underpins clinical research and commercialization operations for many of the world’s leading biopharmaceutical organizations. (more…)